Outpatient transfusion practice and factors leading to inpatient transfusion in a pediatric hematology/oncology program

J Pediatr Oncol Nurs. 2007 Jan-Feb;24(1):46-51. doi: 10.1177/1043454206296022.

Abstract

Oral mucositis continues to be a common and debilitating side effect of the conditioning regimens that use high-dose chemotherapy with or without radiation for pediatric bone marrow transplantation. Limited interventions have demonstrated success in preventing or treating it. Administration of glutamine, which is a nitrogen-rich amino acid found in the body, has emerged as a possible method of preventing oral mucositis in patients undergoing bone marrow transplantation. Numerous studies have looked at the effects of oral glutamine supplementation during bone marrow transplant. The purpose of this article is to describe glutamine and how it functions, review the literature regarding the use of oral glutamine in the prevention of oral mucositis in bone marrow transplantion, discuss the administration concerns related to the pediatric setting, and stress the importance of the nurse's role at the bedside. Nurses working in pediatric bone marrow transplant play a key role in the assessment of oral mucositis, administration of oral glutamine, and education of the patient and family.

MeSH terms

  • Blood Component Transfusion*
  • Child
  • Continuity of Patient Care
  • Hematologic Diseases / therapy*
  • Humans
  • Inpatients*
  • Neoplasms / therapy*
  • Outpatients*